CJ to co-promote Herben, anti-hypertensive product
Published: 2008-05-23 06:56:00
Updated: 2008-05-23 06:56:00
CJ CheilJedang says it has recently signed an agreement with Mitsubishi Tanabe Pharma Corporation and Welfide Korea to co-market an old-version calcium channel blocker Herben, which was developed by Tanabe Seiyaku and launched in 1981 in Korea.
Under the agreement, CJ will be responsible for p...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
